Emcure Pharmaceuticals - Share Price & Details
High price all time
1,580
Peer Comparison
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Limited has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
Company Updates
Load More
Quarterly Table
Metrics Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sales 970.3 1,104.6 1,028.8 1,278.2 1,096.6 Expenses 855.1 952.5 904.4 1,033.5 868.6 Operating Profit 115.2 152.2 124.4 244.7 228.0 OPM % 11.87% 13.77% 12.09% 19.14% 20.79% Other Income 32.5 54.9 19.4 22.4 18.0 Interest 37.6 31.4 19.9 24.1 20.5 Depreciation 55.1 56.3 56.6 56.9 59.8 Profit before tax 55.0 119.4 67.3 186.1 169.2 Tax % 26.5% -27.2% -25.3% -24.9% 25.9% Net Profit 40.4 86.9 50.2 139.6 122.8 EPS in Rs 2.23 4.62 2.65 0 6.48
Metrics Jun 2024 Sep 2024 Dec 2024 Mar 2025 Sales 1,815.1 2,002.0 1,962.6 2,116.2 Expenses 1,478.8 1,621.1 1,608.0 1,713.8 Operating Profit 336.3 380.9 354.6 402.4 OPM % 18.53% 19.02% 18.07% 19.02% Other Income 23.4 35.7 3.9 -5.9 Interest 58.8 46.2 31.8 39.0 Depreciation 93.6 96.9 96.8 96.8 Profit before tax 207.4 273.4 229.9 271.0 Tax % -26.4% 26.3% 32.1% -24.3% Net Profit 152.6 201.5 156.1 197.2 EPS in Rs 7.95 10.33 8.12 0
Shareholding Distribution
Shareholding Pattern
Compounded Data
Compounded Sales
Growth
10 Years:
0%
5 Years:
13%
3 Years:
9%
TTM:
25%
Compounded Profit
Growth
10 Years:
0%
5 Years:
9%
3 Years:
-11%
TTM:
95%
Stock Price CAGR
10 Years:
0%
5 Years:
0%
3 Years:
0%
1 Year:
0%
Compounded Sales
Growth
10 Years:
0%
5 Years:
9%
3 Years:
10%
TTM:
19%
Compounded Profit
Growth
10 Years:
0%
5 Years:
36%
3 Years:
1%
TTM:
37%
Stock Price CAGR
10 Years:
0%
5 Years:
0%
3 Years:
0%
1 Year:
0%
